{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:25:02Z","timestamp":1769048702280,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,6]],"date-time":"2010-03-06T00:00:00Z","timestamp":1267833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00280-010-1272-6","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T02:30:18Z","timestamp":1267756218000},"page":"5-11","source":"Crossref","is-referenced-by-count":19,"title":["Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding"],"prefix":"10.1007","volume":"67","author":[{"given":"Moon Ki","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Jin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Seok","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Sung","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hyung","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Seok","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Oh","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Yeong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Ki","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,6]]},"reference":[{"issue":"Suppl 3","key":"1272_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1634\/theoncologist.10-90003-49","volume":"10","author":"JA Ajani","year":"2005","unstructured":"Ajani JA (2005) Evolving chemotherapy for advanced gastric cancer. Oncologist 10(Suppl 3):49\u201358","journal-title":"Oncologist"},{"key":"1272_CR2","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","volume":"335","author":"DS Alberts","year":"1996","unstructured":"Alberts DS, Liu PY, Hannigan EV, O\u2019Toole R, Williams SD, Young JA, Franklin EW, Clarke-Pearson DL, Malviya VK, DuBeshter B (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 335:1950\u20131955","journal-title":"N Engl J Med"},{"key":"1272_CR3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34\u201343","journal-title":"N Engl J Med"},{"key":"1272_CR4","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2004.01.140","volume":"22","author":"O Bouche","year":"2004","unstructured":"Bouche O, Raoul JL, Bonnetain F, Giovannini M, Etienne PL, Lledo G, Arsene D, Paitel JF, Guerin-Meyer V, Mitry E, Buecher B, Kaminsky MC, Seitz JF, Rougier P, Bedenne L, Milan C (2004) Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie digestive group study\u2014FFCD 9803. J Clin Oncol 22:4319\u20134328","journal-title":"J Clin Oncol"},{"key":"1272_CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdf019","volume":"13","author":"D Elias","year":"2002","unstructured":"Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El OA, Pignon JP, Drouard-Troalen L, Ouellet JF, Ducreux M (2002) Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol 13:267\u2013272","journal-title":"Ann Oncol"},{"key":"1272_CR6","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/annonc\/mdh398","volume":"15","author":"D Elias","year":"2004","unstructured":"Elias D, Matsuhisa T, Sideris L, Liberale G, Drouard-Troalen L, Raynard B, Pocard M, Puizillou JM, Billard V, Bourget P, Ducreux M (2004) Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 15:1558\u20131565","journal-title":"Ann Oncol"},{"key":"1272_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archsurg.139.1.20","volume":"139","author":"O Glehen","year":"2004","unstructured":"Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D, Freyer G, Francois Y, Vignal J, Gilly FN (2004) Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 139:20\u201326","journal-title":"Arch Surg"},{"key":"1272_CR8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s002800050801","volume":"42","author":"S Guichard","year":"1998","unstructured":"Guichard S, Chatelut E, Lochon I, Bugat R, Mahjoubi M, Canal P (1998) Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice. Cancer Chemother Pharmacol 42:165\u2013170","journal-title":"Cancer Chemother Pharmacol"},{"key":"1272_CR9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0140-6736(92)90792-2","volume":"339","author":"A Hagiwara","year":"1992","unstructured":"Hagiwara A, Takahashi T, Kojima O, Sawai K, Yamaguchi T, Yamane T, Taniguchi H, Kitamura K, Noguchi A, Seiki K et al (1992) Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 339:629\u2013631","journal-title":"Lancet"},{"key":"1272_CR10","first-page":"1715","volume":"50","author":"N Kaneda","year":"1990","unstructured":"Kaneda N, Nagata H, Furuta T, Yokokura T (1990) Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse. Cancer Res 50:1715\u20131720","journal-title":"Cancer Res"},{"key":"1272_CR11","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/sj.bjc.6602575","volume":"92","author":"ST Kim","year":"2005","unstructured":"Kim ST, Kang WK, Kang JH, Park KW, Lee J, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Park YS, Im YH, Park K (2005) Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer. Br J Cancer 92:1850\u20131854","journal-title":"Br J Cancer"},{"key":"1272_CR12","first-page":"960","volume":"54","author":"Y Kodera","year":"2007","unstructured":"Kodera Y, Ito Y, Ito S, Ohashi N, Mochizuki Y, Yamamura Y, Koike M, Fujiwara M, Nakanishi H, Nakao A (2007) Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma. Hepatogastroenterology 54:960\u2013963","journal-title":"Hepatogastroenterology"},{"key":"1272_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jso.20161","volume":"89","author":"V Makrin","year":"2005","unstructured":"Makrin V, Lev-Chelouche D, Even Sapir E, Paran H, Rabau M, Gutman M (2005) Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: an animal study. J Surg Oncol 89:18\u201322","journal-title":"J Surg Oncol"},{"key":"1272_CR14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"M Markman","year":"2001","unstructured":"Markman M, Bundy BN, Alberts DS, Fowler JM, Clark-Pearson DL, Carson LF, Wadler S, Sickel J (2001) Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the gynecologic oncology group, Southwestern oncology group, and Eastern cooperative oncology group. J Clin Oncol 19:1001\u20131007","journal-title":"J Clin Oncol"},{"key":"1272_CR15","first-page":"4187","volume":"19","author":"M Maruyama","year":"1999","unstructured":"Maruyama M, Nagahama T, Yuasa Y (1999) Intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis. Anticancer Res 19:4187\u20134191","journal-title":"Anticancer Res"},{"key":"1272_CR16","first-page":"1505","volume":"28","author":"M Maruyama","year":"2001","unstructured":"Maruyama M, Toukairin Y, Baba H, Kure N, Nagahama T, Ebuchi M (2001) Pharmacokinetic study of the intraperitoneal administration of CPT-11 for patients with peritoneal seedings of gastric and colonic cancers. Gan To Kagaku Ryoho 28:1505\u20131507","journal-title":"Gan To Kagaku Ryoho"},{"key":"1272_CR17","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/sj.bjc.6602649","volume":"92","author":"M Moehler","year":"2005","unstructured":"Moehler M, Eimermacher A, Siebler J, Hohler T, Wein A, Menges M, Flieger D, Junginger T, Geer T, Gracien E, Galle PR, Heike M (2005) Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer. Br J Cancer 92:2122\u20132128","journal-title":"Br J Cancer"},{"key":"1272_CR18","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1200\/JCO.1998.16.8.2733","volume":"16","author":"HR Rosen","year":"1998","unstructured":"Rosen HR, Jatzko G, Repse S, Potrc S, Neudorfer H, Sandbichler P, Zacherl J, Rabl H, Holzberger P, Lisborg P, Czeijka M (1998) Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian working group for surgical oncology. J Clin Oncol 16:2733\u20132738","journal-title":"J Clin Oncol"},{"key":"1272_CR19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000421-200212000-00019","volume":"25","author":"E Topuz","year":"2002","unstructured":"Topuz E, Basaran M, Saip P, Aydiner A, Argon A, Sakar B, Tas F, Uygun K, Bugra D, Aykan NF (2002) Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study. Am J Clin Oncol 25:619\u2013624","journal-title":"Am J Clin Oncol"},{"key":"1272_CR20","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737\u20133743","journal-title":"J Clin Oncol"},{"key":"1272_CR21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2004.03.018","volume":"210","author":"Y Yonemura","year":"2004","unstructured":"Yonemura Y, Endou Y, Bando E, Kuno K, Kawamura T, Kimura M, Shimada T, Miyamoto K, Sasaki T, Sugarbaker PH (2004) Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. Cancer Lett 210:189\u2013196","journal-title":"Cancer Lett"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1272-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-010-1272-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1272-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T06:07:06Z","timestamp":1559023626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-010-1272-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,6]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1272"],"URL":"https:\/\/doi.org\/10.1007\/s00280-010-1272-6","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,6]]}}}